| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M208539200 |
| P8608 | Fatcat ID | release_ri3is52spba63emz6wmggptd7m |
| P3181 | OpenCitations bibliographic resource ID | 3907421 |
| P698 | PubMed publication ID | 12221107 |
| P5875 | ResearchGate publication ID | 11168591 |
| P50 | author | Helen Hobbs | Q21433424 |
| Jonathan C. Cohen | Q24063837 | ||
| P2093 | author name string | Ming Yi | |
| Guocheng He | |||
| Peter Michaely | |||
| Sarita Gupta | |||
| P2860 | cites work | The mu2 subunit of the clathrin adaptor AP-2 binds to FDNPVY and YppØ sorting signals at distinct sites | Q24301593 |
| Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain | Q24536014 | ||
| The structure and function of the beta 2-adaptin appendage domain | Q24599597 | ||
| Peptide-in-groove interactions link target proteins to the beta-propeller of clathrin | Q27621166 | ||
| Further additions to MolScript version 1.4, including reading and contouring of electron-density maps | Q27860974 | ||
| Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase | Q28131695 | ||
| The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits | Q28142257 | ||
| Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein | Q28186061 | ||
| Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis | Q28207619 | ||
| beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin | Q28214555 | ||
| Clathrin and adaptors | Q28280468 | ||
| Enhanced morphine analgesia in mice lacking beta-arrestin 2 | Q28504554 | ||
| A requirement for ankyrin binding to clathrin during coated pit budding | Q28579368 | ||
| Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor | Q29618735 | ||
| Diversity in protein recognition by PTB domains | Q33801830 | ||
| Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia | Q33857941 | ||
| The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors | Q34196707 | ||
| Clathrin-binding proteins: got a motif? Join the network! | Q34328624 | ||
| Dockers at the crossroads | Q34465504 | ||
| Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins | Q34568617 | ||
| Clathrin adaptors really adapt | Q34709976 | ||
| Tissue-specific sorting of the human LDL receptor in polarized epithelia of transgenic mice | Q36223333 | ||
| The LDL receptor clustering motif interacts with the clathrin terminal domain in a reverse turn conformation | Q36256170 | ||
| Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism | Q39289456 | ||
| The NPXY internalization signal of the LDL receptor adopts a reverse-turn conformation | Q67802007 | ||
| Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia | Q74598521 | ||
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Low density lipoprotein receptor adaptor protein 1 | Q6693000 |
| low-density lipoprotein particle receptor binding | Q14890332 | ||
| AP-2 adaptor complex binding | Q21106401 | ||
| Low density lipoprotein receptor adaptor protein 1 | Q21496937 | ||
| P304 | page(s) | 44044-9 | |
| P577 | publication date | 2002-11-15 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2 | |
| P478 | volume | 277 |
| Q34432614 | A clathrin coat assembly role for the muniscin protein central linker revealed by TALEN-mediated gene editing. |
| Q42456078 | A dual role of the N-terminal FQQI motif in GLUT4 trafficking |
| Q33792902 | A phosphotyrosine switch for cargo sequestration at clathrin-coated buds |
| Q30478248 | A single common portal for clathrin-mediated endocytosis of distinct cargo governed by cargo-selective adaptors |
| Q24296494 | AMN directs endocytosis of the intrinsic factor-vitamin B(12) receptor cubam by engaging ARH or Dab2 |
| Q30430390 | ARH cooperates with AP-1B in the exocytosis of LDLR in polarized epithelial cells |
| Q36992932 | ARH directs megalin to the endocytic recycling compartment to regulate its proteolysis and gene expression |
| Q28269595 | Adaptor protein ARH is recruited to the plasma membrane by low density lipoprotein (LDL) binding and modulates endocytosis of the LDL/LDL receptor complex in hepatocytes |
| Q33638980 | Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond |
| Q35883857 | Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other |
| Q28155799 | Assembly of Cell Regulatory Systems Through Protein Interaction Domains |
| Q28564763 | Association of the low-density lipoprotein receptor with caveolae in hamster and rat liver |
| Q43104582 | Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing |
| Q27678570 | Atomic structure of the autosomal recessive hypercholesterolemia phosphotyrosine-binding domain in complex with the LDL-receptor tail |
| Q45107252 | Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment |
| Q24305128 | Autosomal recessive hypercholesterolemia protein interacts with and regulates the cell surface level of Alzheimer's amyloid beta precursor protein |
| Q30417272 | BRAG2/GEP100/IQSec1 interacts with clathrin and regulates α5β1 integrin endocytosis through activation of ADP ribosylation factor 5 (Arf5). |
| Q36279579 | Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer |
| Q33435708 | Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease |
| Q34382206 | Cargo recognition in clathrin-mediated endocytosis |
| Q33751689 | Cargo- and adaptor-specific mechanisms regulate clathrin-mediated endocytosis. |
| Q35818355 | Cargo- and compartment-selective endocytic scaffold proteins |
| Q24338638 | Characterization of the adaptor protein ARH expression in the brain and ARH molecular interactions |
| Q37185321 | Clathrin regulates the association of PIPKIgamma661 with the AP-2 adaptor beta2 appendage |
| Q30822201 | Comparative analysis of adaptor-mediated clathrin assembly reveals general principles for adaptor clustering. |
| Q39352302 | Detecting subnetwork-level dynamic correlations |
| Q28505513 | Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways |
| Q35533766 | Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions |
| Q35250984 | Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia |
| Q40134407 | Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation |
| Q40599670 | Endocytic adaptor molecules reveal an endosomal population of clathrin by total internal reflection fluorescence microscopy |
| Q36482783 | Endocytic pathways involved in filovirus entry: advances, implications and future directions. |
| Q24304997 | FCH domain only-2 organizes clathrin-coated structures and interacts with Disabled-2 for low-density lipoprotein receptor endocytosis |
| Q35647668 | FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors |
| Q41779360 | Familial hypercholesterolaemia |
| Q26781439 | Forty Years of Clathrin-coated Vesicles |
| Q24296418 | Functional dissection of an AP-2 beta2 appendage-binding sequence within the autosomal recessive hypercholesterolemia protein |
| Q37362304 | Functional roles of short sequence motifs in the endocytosis of membrane receptors |
| Q33564499 | Genetic analysis of the neuronal and ubiquitous AP-3 adaptor complexes reveals divergent functions in brain. |
| Q34281148 | Genetic, anatomic, and clinical determinants of human serum sterol and vitamin D levels |
| Q37033185 | Host cell factors and functions involved in vesicular stomatitis virus entry |
| Q42112172 | Identification of a VLDL-induced, FDNPVY-independent internalization mechanism for the LDLR. |
| Q36708971 | Influence of PDZK1 on lipoprotein metabolism and atherosclerosis |
| Q35938094 | LDL-receptor mutations in Europe |
| Q50299785 | LDL:LDLR complex [plasma membrane] => LDL:LDLR complex [clathrin-coated vesicle] (LDLRAP1-independent) |
| Q50299923 | LDLR is bound by DAB2 and ARH |
| Q40156586 | LRP: a bright beacon at the blood-brain barrier |
| Q28258969 | Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor |
| Q40542671 | Macrophage colony-stimulating factor differentially regulates low density lipoprotein and transferrin receptors. |
| Q36075377 | MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis |
| Q36145238 | Molecular characterization of proprotein convertase subtilisin/kexin type 9-mediated degradation of the LDLR. |
| Q37972887 | Molecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins |
| Q24672834 | Monogenic hypercholesterolemia: new insights in pathogenesis and treatment |
| Q35581908 | New Light on a Long‐Known Protein Family |
| Q28204028 | Normal Sorting but Defective Endocytosis of the Low Density Lipoprotein Receptor in Mice with Autosomal Recessive Hypercholesterolemia |
| Q27641195 | Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes |
| Q24310854 | PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2 |
| Q38921625 | Pathways of protein and lipid receptor-mediated transcytosis in drug delivery. |
| Q38336252 | Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. |
| Q94466073 | Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer's Disease |
| Q34723257 | Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1) |
| Q27009477 | Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseases |
| Q33796356 | Reciprocal regulation of endocytosis and metabolism |
| Q24302853 | Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 gamma-sigma1 and AP-3 delta-sigma3 hemicomplexes |
| Q39263076 | Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB. |
| Q24323051 | Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1 |
| Q34975192 | Role of an intramolecular contact on lipoprotein uptake by the LDL receptor |
| Q21092775 | Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly |
| Q33767978 | Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI |
| Q36822549 | S-nitrosylation of ARH is required for LDL uptake by the LDL receptor |
| Q24311328 | Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice |
| Q34381865 | Small peptide recognition sequence for intracellular sorting |
| Q40598692 | Soluble LDL-R are formed by cell surface cleavage in response to phorbol esters |
| Q35569243 | Sorting it out: AP-2 and alternate clathrin adaptors in endocytic cargo selection |
| Q45071198 | Stx5 is a novel interactor of VLDL-R to affect its intracellular trafficking and processing |
| Q38024048 | Synaptic vesicle endocytosis |
| Q28208721 | Targeted Disruption of the PDZK1 Gene in Mice Causes Tissue-specific Depletion of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I and Altered Lipoprotein Metabolism |
| Q36589179 | Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances |
| Q36992906 | The AP-2 adaptor beta2 appendage scaffolds alternate cargo endocytosis |
| Q37403077 | The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney |
| Q24297020 | The Adaptor Protein ARH Escorts Megalin to and through Endosomes |
| Q35621350 | The GGA proteins: adaptors on the move |
| Q37002668 | The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation |
| Q24338811 | The NECAP PHear domain increases clathrin accessory protein binding potential |
| Q40639637 | The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor |
| Q34580436 | The clathrin adaptor proteins ARH, Dab2, and numb play distinct roles in Niemann-Pick C1-Like 1 versus low density lipoprotein receptor-mediated cholesterol uptake. |
| Q40075586 | The connecdenn family, Rab35 guanine nucleotide exchange factors interfacing with the clathrin machinery. |
| Q36714128 | The cytosolic adaptor AP-1A is essential for the trafficking and function of Niemann-Pick type C proteins |
| Q30482500 | The endocytic adaptor protein ARH associates with motor and centrosomal proteins and is involved in centrosome assembly and cytokinesis. |
| Q39160284 | The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells |
| Q42749068 | The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586. |
| Q29615234 | The mechanisms of vesicle budding and fusion |
| Q24294525 | The modular adaptor protein ARH is required for low density lipoprotein (LDL) binding and internalization but not for LDL receptor clustering in coated pits |
| Q40369997 | The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits |
| Q37357958 | The role of calcium in lipoprotein release by the low-density lipoprotein receptor |
| Q38980152 | Using human genetics to discover new therapeutic targets for plasma lipids |
| Q45723157 | Weak Molecular Interactions in Clathrin-Mediated Endocytosis |
| Q44565939 | Xenopus autosomal recessive hypercholesterolemia protein couples lipoprotein receptors with the AP-2 complex in oocytes and embryos and is required for vitellogenesis |
Search more.